跳至主要内容
临床试验/CTRI/2018/05/013729
CTRI/2018/05/013729尚未招募4 期

A Single-Blind Randomised Controlled Clinical Study Comparing the Efficacy, Tolerability and Safety of Levocetrizine and Bepotastine in Chronic Urticaria

Institutional0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age 18 yrs to 85 years
  • Near daily appearance of wheals for more than 6 weeks
  • Urticaria Activity Score 7 (UAS 7) more than equal to 14
  • Informed consent obtained
  • Willing for weekly follow-up and injections

排除标准

  • Pregnant and lactating women
  • Immunosuppressed due to drug or disease
  • Allergy to Levocetirizine
  • Concomitant systemic illness requiring treatment
  • Mental illness interfering with perception of urticarial symptoms
  • Subjects working in night shifts or are likely to change the usual sleep/ wake cycle
  • Patients driving automobiles
  • Participation in any clinical trial within the last 3 months
  • Any other condition, which in the opinion of the investigators, is not conducive to inclusion of the subject in the trial
  • Substance or alcohol abuse

研究者

发起方
Institutional

相似试验